Literature Review

Availability and Use of EU Databases to Generate Health Economic Evidence

Databases are essential tools for pharmacoeconomic research. While North America has large administrative claims databases, hospital databases, and electronic medical record systems, databases in Europe are scarcer, integrated primary and secondary care data are rare, and claims with corresponding cost values are largely non-existent.


ISPOR Abstracts Highlight the Value of Real-World Evidence

At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting, conducted May 21-25, 2-16, in Washington, DC,  industry professionals convened to delve into the topic “Value, Affordability, and Patient Centeredness: Can We Have it All?” UBC’s Value Demonstration experts joined the conversation with five abstracts highlighting some of their recentresearch.


Literature Reviews Demonstrate Real-World Drug Safety

There is increasing demand from payers to gather evidence on the safety of medications used in the general population post-commercialization. Conducting a literature review involving critical appraisal is essential to better understand the research topic and assess the validity of the research findings. UBC can conduct literature reviews and other real-world evidence generation studies for your product.


4 Drivers for Successful Literature Reviews

Evidentiary requirements in support of market access and reimbursement span the entire drug development lifecycle. A critical evidence gathering approach includes one or more reviews of literature to leverage published data on epidemiological outcomes, effectiveness, safety, burden and cost of illness, and health care utilization and care processes. These four key considerations will drive successful literature reviews.

Subscribe to RSS - Literature Review